Generation Bio Co
NASDAQ:GBIO

Watchlist Manager
Generation Bio Co Logo
Generation Bio Co
NASDAQ:GBIO
Watchlist
Price: 2.05 USD -5.96% Market Closed
Market Cap: 136.8m USD
Have any thoughts about
Generation Bio Co?
Write Note

Intrinsic Value

GBIO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one GBIO stock under the Base Case scenario is 1.12 USD. Compared to the current market price of 2.05 USD, Generation Bio Co is Overvalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GBIO Intrinsic Value
1.12 USD
Overvaluation 45%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Generation Bio Co

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GBIO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GBIO?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Generation Bio Co

Provide an overview of the primary business activities
of Generation Bio Co.

What unique competitive advantages
does Generation Bio Co hold over its rivals?

What risks and challenges
does Generation Bio Co face in the near future?

Has there been any significant insider trading activity
in Generation Bio Co recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Generation Bio Co.

Provide P/S
for Generation Bio Co.

Provide P/E
for Generation Bio Co.

Provide P/OCF
for Generation Bio Co.

Provide P/FCFE
for Generation Bio Co.

Provide P/B
for Generation Bio Co.

Provide EV/S
for Generation Bio Co.

Provide EV/GP
for Generation Bio Co.

Provide EV/EBITDA
for Generation Bio Co.

Provide EV/EBIT
for Generation Bio Co.

Provide EV/OCF
for Generation Bio Co.

Provide EV/FCFF
for Generation Bio Co.

Provide EV/IC
for Generation Bio Co.

Show me price targets
for Generation Bio Co made by professional analysts.

What are the Revenue projections
for Generation Bio Co?

How accurate were the past Revenue estimates
for Generation Bio Co?

What are the Net Income projections
for Generation Bio Co?

How accurate were the past Net Income estimates
for Generation Bio Co?

What are the EPS projections
for Generation Bio Co?

How accurate were the past EPS estimates
for Generation Bio Co?

What are the EBIT projections
for Generation Bio Co?

How accurate were the past EBIT estimates
for Generation Bio Co?

Compare the revenue forecasts
for Generation Bio Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Generation Bio Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Generation Bio Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of Generation Bio Co compared to its peers.

Compare the P/E ratios
of Generation Bio Co against its peers.

Discuss the investment returns and shareholder value creation
comparing Generation Bio Co with its peers.

Analyze the financial leverage
of Generation Bio Co compared to its main competitors.

Show all profitability ratios
for Generation Bio Co.

Provide ROE
for Generation Bio Co.

Provide ROA
for Generation Bio Co.

Provide ROIC
for Generation Bio Co.

Provide ROCE
for Generation Bio Co.

Provide Gross Margin
for Generation Bio Co.

Provide Operating Margin
for Generation Bio Co.

Provide Net Margin
for Generation Bio Co.

Provide FCF Margin
for Generation Bio Co.

Show all solvency ratios
for Generation Bio Co.

Provide D/E Ratio
for Generation Bio Co.

Provide D/A Ratio
for Generation Bio Co.

Provide Interest Coverage Ratio
for Generation Bio Co.

Provide Altman Z-Score Ratio
for Generation Bio Co.

Provide Quick Ratio
for Generation Bio Co.

Provide Current Ratio
for Generation Bio Co.

Provide Cash Ratio
for Generation Bio Co.

What is the historical Revenue growth
over the last 5 years for Generation Bio Co?

What is the historical Net Income growth
over the last 5 years for Generation Bio Co?

What is the current Free Cash Flow
of Generation Bio Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for Generation Bio Co.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Generation Bio Co

Current Assets 191.3m
Cash & Short-Term Investments 184.8m
Receivables 2.2m
Other Current Assets 4.3m
Non-Current Assets 57.5m
Long-Term Investments 15m
PP&E 37.2m
Other Non-Current Assets 5.3m
Current Liabilities 30.2m
Accounts Payable 1.7m
Accrued Liabilities 16.6m
Other Current Liabilities 11.9m
Non-Current Liabilities 114.2m
Other Non-Current Liabilities 114.2m
Efficiency

Earnings Waterfall
Generation Bio Co

Revenue
18.6m USD
Operating Expenses
-116.2m USD
Operating Income
-97.7m USD
Other Expenses
-47.8m USD
Net Income
-145.5m USD

Free Cash Flow Analysis
Generation Bio Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GBIO Profitability Score
Profitability Due Diligence

Generation Bio Co's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional 1-Year Revenue Growth
ROIC is Increasing
Positive Revenue Growth Forecast
Declining ROE
23/100
Profitability
Score

Generation Bio Co's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

GBIO Solvency Score
Solvency Due Diligence

Generation Bio Co's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

Generation Bio Co's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GBIO Price Targets Summary
Generation Bio Co

Wall Street analysts forecast GBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GBIO is 7.65 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Lowest
Price Target
5.05 USD
146% Upside
Average
Price Target
7.65 USD
273% Upside
Highest
Price Target
10.5 USD
412% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GBIO?

Click here to dive deeper.

Dividends

Generation Bio Co
does not pay dividends
Shareholder Yield

Current shareholder yield for GBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GBIO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Generation Bio Co Logo
Generation Bio Co

Country

United States of America

Industry

Biotechnology

Market Cap

136.8m USD

Dividend Yield

0%

Description

Generation Bio Co. is a genetic medicine company focused on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 150 full-time employees. The company went IPO on 2020-06-12. The firm through its non-viral genetic medicine platform, is engaged in developing genetic medicines to provide genetic payloads, which include large and multiple genes to a range of cell types across a range of diseases. The company is comprised of three component technologies: ceDNA, ctLNP and ceDNA manufacturing process. ceDNA is an engineered, double-stranded, linear, covalently closed-ended deoxyribonucleic acid (DNA) construct, which includes the gene of interest and associated regulatory sequences. The company has produced ceDNA constructs of approximately eight kilobases. Its ctLNP delivery system builds upon clinically validated lipid nanoparticles and is designed to allow for repeat dosing of a genetic payload without stimulating an immune response, such as antibody production. Its ceDNA manufacturing process uses its own cell-free rapid enzymatic synthesis (RES) to produce ceDNA.

Contact

MASSACHUSETTS
Cambridge
301 Binney Street
+18575295908.0
generationbio.com

IPO

2020-06-12

Employees

150

Officers

President, CEO & Director
Dr. Cameron Geoffrey McDonough M.D.
Chief Financial Officer
Dr. Matthew Norkunas M.B.A., M.D.
Chief Scientific Officer
Dr. Matthew Stanton Ph.D.
Chief Legal Officer & Secretary
Ms. Yalonda Howze J.D.
Co-Founder
Dr. Robert Kotin Ph.D.
Chief Operating Officer
Ms. Antoinette Paone M.B.A., M.S.
Show More
Chief Human Resources Officer
Ms. Jasmin Tower
Chief Strategy Officer
Dr. Phillip Samayoa Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one GBIO stock?

The intrinsic value of one GBIO stock under the Base Case scenario is 1.12 USD.

Is GBIO stock undervalued or overvalued?

Compared to the current market price of 2.05 USD, Generation Bio Co is Overvalued by 45%.

Back to Top